and Joe good everyone. Thanks, morning
half at the in We of stable, Florida the many third We grow growth modestly in are performance Texas, stay delivered most accelerate strong significantly in our Consumer very we acceleration was Joe noted, have XXXX. the us third XXXX quarter, with of quarter continued confidence organic pleased throughout a levels. which Medical that the sales the year growth what segment, Puerto segment hurricanes we declined Pharmaceutical strength negative the to as relatively half and The second that was as highlights results. the to impact exactly That Devices to grew of while given to the The would experienced oncology minor but experienced and Rico. immunology products in first in in due robust areas in third business growth our quarter.
In addition, continue we fuel will our performance Optics acquisitions are Medical Actelion very to pleased from our growth. recent the which with and
adjusted X% regarding share. in $XXX sales overall to of that are to take who those analyst many you impact been million estimates earnings the a of quarter. the especially by been I so, courage acknowledge the have moment beat know also And the storms there impressive the unprecedented resilience been by and response the Johnson per these and want beat or storms. for really of estimates community has analyst I am $X.XX by approximately questions occurred impacted The has business incredible. all directly role played. Johnson & and of proud of It’s global I
united the really side-by-side and when to our it the communities improve foundational of proved. element Our credo effort have like working ground these who on lives character is a shines people relief their in with times to desire organizations, our and help is been
limited quarter quarters, but associated in future is the the of of experienced In storms. positioned. disruption, we of in rather are very days the be seen sales, terms terms surgeries lost result recouped third by in future affected the supply, be those supply lost It those in surgery areas well impact will whether with volumes remains not to any however, we
sites on We six of the fared storm, manufacturing facilities Rico have considering and magnitude Puerto well. island the our of the
ensure open inventories the with in island. generator manufactured and work closely newly of global have Rico. needs monitoring capacity we in manufacturing already to across prioritizing operations products are are sites various up full our patient to while are option ramp our stages Puerto of shipping power from continues begun met, All network operating reliable essential of goods critical To the
cannot demand. of of results. to turn help Rico not of for many back-up third of Based we outside future on production While the what rule do any the product have certain shortages consolidated meet products formats, know dual we sites Puerto will I intermittent impact our foresee our quarter out for supply potential and today, we earnings now of to material statement to XXXX.
this X.X% was sales growth As and operational divestitures, our of quarter you X.X%. impact growth and the heard, was acquisitions operational excluding
have exclude If your we section expense you will attention the see you to provided box schedule items. to earnings amortization of direct and will intangible our the special adjusted
approximately As for recent exclude special of million, the primarily referenced after-tax expense measures the of our a Actelion, basis, primarily of $X.X were $XXX million. of intangible amortization of restructuring XXXX Hospital quarter of acquisition expense of billion consisted million and continuing of $XXX charge $XXX adjusted in expenses of approximately $XXX approximately to amortization following. to table Medical third an the from non-GAAP cost business approximately items litigation the million, and net acquisition-related Device earnings Intangible on which
the EPS Our constant adjusted basis up adjusted or earnings share a currency is $X.XX, per was XX% therefore and $X.XX XX% up over year. on prior
points, inclusion acquisitions. for primarily of the about our the basis XXX step-up goods expense to of charges Now by let’s earnings. to inventory items take due few from and the amortization talk moments other recent Cost on of increased statement a the
of of in largely new the points to the of of basis both Excluding impact second the points Selling, XXXX, and segment. product prior our basis to quarter favorable expenses expenses mostly was lower types up due cost periods, XX.X% sold or mix. of goods year, these in investment through the marketing compared Consumer as than administrative were XX XXX products
higher of and interest a robust was And interest XX pharmaceutical XX.X%, of development million $XXX as $XXX expense, net quarter a expense our last the we prior was points compared to net year. net a Our than to income $XX million, compared to of investment advance basis income same in gain up last Other a in gain the of continue products. net in as and research was year of million sales of slightly the expense percent pipeline year. period
$XXX an I’ll a which items special comments. completion million, that compared period activity sales and the annual in certain year gain of reflecting our recorded were this asset to provide of update included a line, prior are my during of guidance. this expense Excluding $XXX in million income guidance gain on net other net in was
tax items, also This of compared a year. rate. the during effective year as the period XX.X% full special our component guidance was same provide effective an rate expectations rate I’ll comments. XX.X% last to is consistent Excluding the tax the with update tax on in my
tax to line driven quarter of quarter by mentioned I the before versus Turning the other now our slide, expense third earlier. the In before investments additional the segment. adjusted the by income XXXX next improved income will I basis partially by of and income XX third review adjusted enterprise favorability tax for in XXXX, offset points
at pre-tax margins segment, new prior by investment to primarily increased income to is Devices divestiture the higher and Looking launches. Pharmaceutical XX% by the gains, lower to XXX Consumer support favorable product Medical margins improved partially by points the due XX.X% primarily spend to improved than spending. to driven adjusted mix. advertising product due promotional offset at year basis XX%
will provide for which of debt, as consider your $XX I you of your our of with the is and of models end of for net $XXX you Therefore, and billion and we other for $XXX consider cash Now expense $XX of significant of modeling At purposes models uses no guidance. you consistent approximately to approximately marketable which some net assuming I and debt. billion refine previous had consisted the securities $XX XXXX. of interest billion million quarter, total million suggest cash, guidance
investments by this we asset a such write-offs. account and and arising our the income sales where losses divestitures, gains as Development well items Corporation, litigation, expense, and reminder income is other record as royalty Regarding from as as
the reflecting with back previous Codman XXXX gain gains for the billion. those items gain, includes with to to our ranging of the our and our of neurosurgery from of subsequent redeploying one most the net is approximately This billion portfolio growth $X.X special value associated creation we expense comfortable priorities quarter. into actively income other we excluding $X.X manage long-term maximize know, business models to guidance, which are of with with still your you our sale to prospects. the to net enhance the intention As a third business Consistent business as closed
we that slightly gains guidance now is to divestiture Regarding the by will word I we investment we maintain This flat from increase course and expect margin, operating mentioned. that taxes. XXXX offset be levels pretax level. just therefore of will our on a decrease And
Financial Chief U.S. the on As am I multinational often tax days reform. about Officer one based the largest of of perspective asked companies, these
I peers In been topic industries. with across my more as have engaged fact, in for well is a ten as actively years it than legislators, many
now our not have about momentum are today in the near reform tax I measures, reform very as some does any business attain and impactful share potential meaningful While include believe guidance like to assumptions we I’d do tax to there future. points
economy not business field our U.S. globally to fueling these as modern rate income still for tax countries, of addresses and needed The impact with a of jumpstarting increasingly the unite optimistic playing tax remaining commend we current we growth. on and fundamental ability the business domestic not multinational see assuming reform include this we Having kept U.S. companies a to has the and greater without in community compete environment with clarity our a the business lower other to and results system front some in economic are that global do detail and elements, reform a in economy, XXXX guidance. U.S. leaders in tax in corporate taking reform cash jobs U.S. it incentives investment and can framework on companies line tax each competitive other compete that get U.S. to reforms united of should have the pace still allowing innovation industrialized penalty innovation-driven will said To manage countries, that on their level jobs tax difficult for while and globally. of The elements U.S. thoughtful Washington and that course done, three that approach the address the an based bill all effectively. important positive industrialized more a for International with behind elements, something adoption will which companies one that framework is now modern, tax in First, additional tax Washington improve system steps U.S. are
a items, special to guidance range Excluding rate slight our is XX.X% guidance. previous as effective the at of tax from our is XX% and tightening this
turning Now earnings. and sales to
any RISPERDAL SUSTENNA. INVEGA guidance CONSTA, Our XXXX ZYTIGA, for this from competition anticipate sales PROCRIT, generic for not impact does PREZISTA year or
a As reflecting is business business. we've of be performance will understanding for constant done our our This several a manage on our basis, from operations. currency good first way years, of our guidance we results the and underlying based the provides
the We results. course our on and an also for results EPS will estimate have of exchange current of provide of that impact with the sales translation XXXX rates those could
As year, maintain the expect earlier, remain the Medical this we earlier of year Optics completed Actelion our balance to mentioned on the major and acquisitions of track. I growth underlying our sales of and acceleration for
of in for X.X% basis. is $XX.X sales currency line we the our our XXXX the of this previous billion expectations, on X%. guidance approximately to the are maintaining range in $XX.X operational translates with This billion constant for year a to sales As
for X.X% And to at to where impact total is previous with our versus movements, points higher last example the sales, We if not of under impact reported guidance. our growth our turning would basis currency $X.XX to billion of sales now scenario, to are year for billion level rates $XX.X currency Thus, idea give week they exchange of you the sales the a growth were the an XX this sales $XX.X the approximately expect of of we X% previous of the earnings. by as reported in guidance. range predicting euro remain for on rate than but expected at were balance increase to which
our those plan we to noted we already an fourth opportunities In of level as quarter, investment launches the from place. in R&D elevated behind year see previous the programs prior with the and as guidance. margins our did expect I to are will pretax well to continue in somewhat continue plans investments in as several Therefore, we earlier, our the in products. third, consistent growth will invest new operating of marketing decline we additional As
We comfortable would reported tightening expect our over our and last by to operational guidance EPS range a a range on negative adjusted and rate in were ranging currency share, movements currency our to EPS the the be from of $X.XX be This X% share impacted per all between due the previous the with guidance. is and Therefore, constant an would an a $X.XX currency our of improvement July basis X.X%. per prior an rate of X.X% remain rates where for reported from favorably and $X.XX an increase that adjusted increase of of exchange we currency of growth reflecting to of XXXX EPS X%. between impact from constant If between and week $X.XX to as $X.XX of adjusted $X.XX and were about is this they in guidance. adjusted $X.XX growth EPS $X.XX of be
for for EPS guidance year, the maintaining and summary, third with we So operational higher to our we sales X% the XXXX. are the our strong businesses performance in consistent pleased on extremely sales of closing, In earnings the growth of quarter growth range earnings are for X.X% term and in and with growing X% of remains our long-term for invest EPS the in sales, adjusted faster our also priorities. than our operational to to guidance continue near delivering while goal X%
of Joe I turn to begin and the Sandy back Jorge like So the to Joaquin, joined am delighted now things be while by I’d questions. Q&A Joe? to your call address portion to to
